The Programme

Program Day One Tuesday October 21 2008

8:30  

Registration

9:00 Julie Jacobs
Director of Project Services
ALMAC

Opening remarks from the Chair

EFFECTIVE CLINICAL SUPPLY MANAGEMENT
9:10 Dick Winokur
Vice President, Clinical Investigational Products, Clinical Supply Chain
SANOFI-AVENTIS

Leveraging software technology to improve the management
of clinical supplies during clinical trials

  • Study planning and setup considerations
  • Study tracking and alignment of supplies with site/patient status
  • Adapting to changing trial conditions and supply requirements
  • Embedding process within technology to enforce standards
  • Utilizing software tools to track supply forecasts vs. site actuals
9:50 Ram Narayanan
Associate Director,
Planning and
Development Operations
BIOGEN IDEC

Managing the function: useful project management techniques

  • Defining the different aspects involved in creating an effective strategy
  • Increasing efficiency and handling more studies with limited resources
  • Tracking and coordinating all projects
  • Setting and meeting appropriate clinical supply metrics
10:30  

Morning refreshments

11:00 Marisa Ehinger
Director New Products and Services
ALMAC

Product pooling: creating efficiencies within your supply chain

  • The real benefits of drug pooling
  • Technologies that support this approach
  • Supply labeling options 
  • Difficulties in implementation - an assessment
RUNNING GLOBAL TRIALS EFFICIENTLY
11:40

Sascha Sonnenberg
Head of Sales and Marketing
Faubel & Co. Nachfolger

Cutting turnaround times for multilingual labels

  • Generation processes for multilingual labels
    • who is involved
    • sources of errors and how to avoid them
    • Comparing scenarios
  • Establishing an efficient process in order to achieve optimal timelines/results: a case study
  • Design guide: a tool to define and specify a unique design
12:20  

Lunch

1:30

Mariamo Abdallah-Bouno
Supply Chain Trial Manager
SANOFI AVENTIS

Part 1: Sanofi-Aventis’ model of managing import/export of IMP/CTM for global studies

  • Overview of s-a functional structure
  • Distribution strategy
  • Requirements for import/export
  • Model advantages
  • Model limitations
  Denise Webber
Clinical and Regulatory Operations Specialist
D.I WEBBER CONSULTING

Part 2: Overview of regulations governing import/export of
IMP/CTM

  • Brief GM-GCP overview regarding IMP manufacture and certification
  • US, EU Member States and other worldwide territories
  • Manufacture and import considerations
  • Labeling considerations
  • Roles and responsibilities
2:10 Andrew Hecht
Director, Regional Accounts
WORLD COURIER

Clinical supply challenges in Russia and Ukraine

  • Geographical size
  • Temperature control in extreme weather conditions
  • Regulatory considerations
  • Case study
2:50  

Afternoon refreshments

3:20 Angus MacLeod
Senior Manager, Global Depot Network
APTUIT LTD

Challenges to controlled drug distribution

  • Exploring trial/molecule specific facility licenses to store and distribute narcotic clinical trial materials
  • Moving clinical trial materials between countries: specific import and export licences needed and obstacles faced
  • Controlled drug capacity at depots
  • Analyzing different country requirements for different schedules of controlled drugs
 EFFECTIVE FORECASTING AND SIMULATION TOOLS
4:00 Edward Tourtellotte
President and CEO
Tourtellotte Solutions

Clinical trials: next generation forecasting and IWR technology

  • A modern end-to-end clinical supply process
  • The overlap between forecasting, simulation and IWR: beyond the boundaries of traditional systems and processes
  • From scratch to sim to launch and back in several minutes
4:40 Sandra Gutierrez
Clinical Supply Project Manager
SCHERING PLOUGH

Improving forecasting abilities throughout the process

  • Understanding the need for effective forecasting and simulation tools
  • Assessing the variety of software available and choosing the best approach
  • Using simulation tools to reduce overage
  • Tailoring forecasting technologies and methodologies to specific studies
5:20  

Closing remarks from the Chair  and close of Day One

Program Day Two Wednesday October 22 2008

8:30  

Registration

9:00 Dick Winokur
Vice President, Clinical Investigational Products, Clinical Supply Chain
SANOFI-AVENTIS

Opening remarks from the Chair:


Roundtable discussions Delegates will be able to attend three one-hour roundtable discussion groups from a selection of key topics. Each session will be chaired by an industry expert who will facilitate an exchange of opinions, essential experiences and learning related to an aspect of clinical trial supply.
 
             
1.

Strategies for supporting adaptive trials

Christopher Stone
R&D Global Supply Operations (GSO)
GLAXOSMITHKLINE

2.

Effective forecasting and simulation tools

Sandra Gutierrez
Clinical Supply Project Manager
SCHERING PLOUGH

3.

Developing an effective supply chain strategy

Scott Rizzo
Former Vice President, Supply Chain Management
BARRIER THERAPEUTICS

 
             
4.

What you should do to plan for comparator supply purchases

Michael Cohen
Managing Director
MYODERM MEDICAL

5.

The nine performance variable model applied to clinical supplies optimization

Chedia Abdelkafi
Director, Clinical Supplies Solutions
N-Side

6.

Optimizing packaging design to assist your clinical sites

Vickie Johnson
Project Manager
ALMAC

 
             
12:30  

Lunch

BEST PRACTICE APPROACHES TO COMPARATOR SUPPLY
1:40 Tony Dutta
Senior Vice President of Operations
IDIS

Michelle Garg
Senior Research Assistant II
WYETH RESEARCH

 Key considerations when sourcing comparators

  • Benefits of formulating a comparator supply strategy at an early stage
  • Overview of available routes of supply for comparator products
  • Validating your suppliers and supply chain: guarding against counterfeit products, assessing the risks of using PI products, assuring confidentiality and handling logistical considerations
  • Identifying the key risks associated with comparator supply that could affect your trial           
  • Choosing a single sourcing strategy: managing single trials involving both the US and EU and evaluating the pros and cons of adopting a single geographic source for your comparator
2:20 Angus Cameron
Director
PHARMARAMA

Sourcing comparators for clinical trials within India

  • Clinical research and the pharmaceutical market in India, an overview
  • ·Exploring the challenges of procuring comparator drugs
  • Reviewing the necessary documentation needed for India
  • Managing the logistics and security of supplying lines
ADAPTING TO NEW TRIAL DESIGNS AND TECHNOLOGY REQUIREMENTS
3:00 Christopher Stone
R&D Global Supply Operations (GSO)
GLAXOSMITHKLINE

Supporting adaptive trials effectively

  • Outlining developments in the adaptive trial arena: current studies, popular designs and trends
  • Examining the impact on the clinical supply department
  • Creating an organizational structure to cope with increased demands, compressed timelines and changing study parameters
3:40   Afternoon refreshments
4:10 Tim Elliott
President
CLINAPPS

System integration in the ever evolving clinical supplies world

  • What is integration and how can it work for you?
  • How can you bring order to the proliferation of tools, ideas and issues?
  • A case study that will work for years to come
  • Why integration will bring long term value to your organization as it evolves
  • How to make your organization process dependent, not people dependent
4:50 Lisa Ortega
Section Manager, Clinical Supply Management
ALLERGAN

Case study: re-engineering Allergan’s clinical supply chain system through leading technology

  • Creating operational excellence
  • Reengineering our processes globally
  • Implementing leading technology solutions
MANAGING IMPORT/EXPORT EFFECTIVELY
5:30 Donna McDermott
Associate Director, Worldwide Regulatory Coordination and Clinical Supplies
MERCK & CO

Case study: importing and exporting clinical materials in and out of the EU and US

  • Ongoing communications with appropriate departments
  • Timing to be included for planning shipping of supplies
  • Sourcing issues for investigational drugs and comparator agents
  • Maintaining flexibility of supplies
  • Import and export process and agencies involved

 

6:10  

Closing remarks from the Chair and champagne prize draw